1. Home
  2. UBXG vs INKT Comparison

UBXG vs INKT Comparison

Compare UBXG & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U-BX Technology Ltd. Ordinary Shares

UBXG

U-BX Technology Ltd. Ordinary Shares

HOLD

Current Price

$1.85

Market Cap

57.8M

Sector

N/A

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$11.04

Market Cap

57.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UBXG
INKT
Founded
2018
2017
Country
China
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.8M
57.6M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
UBXG
INKT
Price
$1.85
$11.04
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
7.0K
10.7K
Earning Date
03-23-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$29,674,534.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.62
$6.34
52 Week High
$4.64
$76.00

Technical Indicators

Market Signals
Indicator
UBXG
INKT
Relative Strength Index (RSI) 41.82 39.47
Support Level $1.86 $10.98
Resistance Level $1.98 $11.48
Average True Range (ATR) 0.10 0.41
MACD -0.00 -0.09
Stochastic Oscillator 16.67 10.93

Price Performance

Historical Comparison
UBXG
INKT

About UBXG U-BX Technology Ltd. Ordinary Shares

U-BX Technology Ltd focuses on providing value-added services using artificial intelligence-driven technology to businesses in the insurance industry, including insurance carriers and brokers. Its main offerings include three services/products: digital promotion services, risk assessment services, and value-added bundled benefits. The PRC operating entities help their institutional clients gain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or clients' promotion time on these channels. U-BX Beijing developed a unique algorithm named the Magic Mirror. The majority of revenue comes from digital promotion services. Geographically, all of the company's revenue is derived from Mainland China.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: